MicroRNA-98 regulates foam cell formation and lipid accumulation through repression of LOX-1

Several miR/s that regulate gene/s relevant in atherogenesis are being described. We identified a miR (miR-98) that targets LOX-1, a receptor for ox-LDL, and speculated that it might be relevant in atherogenesis. MicroRNA-98 was predicted by bioinformatics tools. The effects of miR-98 (by use of mim...

Full description

Saved in:
Bibliographic Details
Published inRedox biology Vol. 16; pp. 255 - 262
Main Authors Dai, Yao, Wu, Xiaoqin, Dai, Dongsheng, Li, Jun, Mehta, Jawahar L.
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 01.06.2018
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Several miR/s that regulate gene/s relevant in atherogenesis are being described. We identified a miR (miR-98) that targets LOX-1, a receptor for ox-LDL, and speculated that it might be relevant in atherogenesis. MicroRNA-98 was predicted by bioinformatics tools. The effects of miR-98 (by use of mimics and inhibitors) on LOX-1 expression and foam cell formation in mouse peritoneal macrophages were assessed. ApoE-/- mice fed by high fat diet were administered with mmu-agomiR-98 and mmu-antagomiR-98, and expression of LOX-1 and foam cell formation in aorta were quantified. LOX-1 was established to be a direct target of miR-98 by luciferase reporter assay. Enhancement of miR-98 decreased the expression of LOX-1 and inhibited foam cell formation and lipid accumulation. Inhibition of miR-98 had the opposite effects on all parameters. Reduced expression of miR-98 may relate to LOX-1 expression and foam cell formation and lipid accumulation in aortas of ApoE-/- mice. Plasma level of miR-98 may be a biomarker of atherosclerotic disease process and its modulation may offer a therapeutic strategy for atherosclerosis. [Display omitted] •miR-98 inhibits LOX-1.•miR-98 inhibits foam cell formation.•miR-98 inhibits lipid accumulation.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2213-2317
2213-2317
DOI:10.1016/j.redox.2018.03.003